FOLH1 and neoplasm: Greifenstein et al. recently demonstrated that a square amide containing DOTAGA-KuE derivative is comparable to the standard compounds PSMA-617 and PSMA-11 in terms of in vitro binding affinity, tumor accumulation, and in vivo kinetics [28].